| scholarly article | Q13442814 |
| P2093 | author name string | Kwo PY | |
| Lasisi F | |||
| P2860 | cites work | Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication | Q24551046 |
| Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 | ||
| Hepatitis C virus infection | Q27861002 | ||
| Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin | Q28256706 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Side effects of therapy of hepatitis C and their management | Q34984142 | ||
| Global epidemiology and burden of hepatitis C. | Q35017766 | ||
| Predictors of response to therapy for chronic hepatitis C. | Q35877904 | ||
| Hepatitis C virus in dermatology. A review | Q40422164 | ||
| Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C. | Q40811419 | ||
| Photoallergic skin reaction to ribavirin. | Q50587652 | ||
| P433 | issue | 10 | |
| P921 | main subject | pegylated interferon | Q7160835 |
| P304 | page(s) | 719-720 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Gastroenterology & hepatology | Q26842161 |
| P1476 | title | Injection Site Bullous Eruption and Generalized Rash Induced by Pegylated Interferon Treatment for Hepatitis C. | |
| P478 | volume | 5 |
Search more.